David Pendarvis - Feb 3, 2023 Form 4 Insider Report for RESMED INC (RMD)

Signature
David Pendarvis, Chief Administrative Officer
Stock symbol
RMD
Transactions as of
Feb 3, 2023
Transactions value $
-$336,750
Form type
4
Date filed
2/6/2023, 12:55 PM
Previous filing
Jan 5, 2023
Next filing
Mar 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Sale -$337K -1.5K -1.54% $224.50 95.7K Feb 3, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan.